Family ties
Recent articles
How ordinary people influence autism research
The builders: How parents shaped autism research
A group of savvy parents jump-started autism research in California, but they also set the research agenda.
The builders: How parents shaped autism research
A group of savvy parents jump-started autism research in California, but they also set the research agenda.
The innovators: How families launch their own autism studies
Some parents are starting ‘N-of-1’ studies for autism, but their efforts don’t always get taken seriously.
The innovators: How families launch their own autism studies
Some parents are starting ‘N-of-1’ studies for autism, but their efforts don’t always get taken seriously.
The seekers: Why parents try fringe therapies for autism
Many parents resort to unproven — even dangerous — alternative treatments for their children’s autism. What drives them?
The seekers: Why parents try fringe therapies for autism
Many parents resort to unproven — even dangerous — alternative treatments for their children’s autism. What drives them?
The pioneers: How parents are experimenting with marijuana for autism
Meet the backyard marijuana growers and home chemists who are rushing in where scientists fear to tread.
The pioneers: How parents are experimenting with marijuana for autism
Meet the backyard marijuana growers and home chemists who are rushing in where scientists fear to tread.
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.